News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Fervo Energy raised $1.89 billion in an upsized IPO, valuing the company near $7.66 billion ahead of its Nasdaq listing.
  • U.S. futures slipped after equities fell on a stronger-than-expected April CPI print, boosting concerns about Fed rate persistence.
  • President Trump said preventing Iran obtaining a nuclear weapon outweighs U.S. economic pain, signaling higher risk of prolonged conflict.
  • U.S. Treasury envoy met China’s vice premier in South Korea to discuss trade, U.S. goods purchases and semiconductor export curbs ahead of the Beijing summit.
  • Oil prices paused after a three-day rally, leaving Brent and WTI elevated amid ongoing supply risks around the Strait of Hormuz.
  • Samsung said pay talks broke down and warned of a potential 18‑day strike that could disrupt AI and chip production.
  • Vietnam’s state oil trader asked U.S. authorities to allow a redirected supertanker to proceed, citing urgent refinery supply needs.

Latest Articles

Beazer Shares Spike After $704 Million All-Cash Proposal from Dream Finders

Beazer Shares Spike After $704 Million All-Cash Proposal from Dream Finders

Shares of Beazer Homes jumped sharply in morning trading after rival builder Dream Finders Homes submitted a $704 million all-cash proposal to buy all outstanding Beazer shares at $25.75 per share. The offer, representing about a 40% premium versus Beazer's May 5, 2026 closing price, is non-binding but was unanimously approved by Dream Finders' boa…

New Jersey Resources Director Jane Kenny Executes $448,800 Stock Sale

New Jersey Resources Director Jane Kenny Executes $448,800 Stock Sale

Jane M. Kenny, a member of the board of directors for New Jersey Resources Corp (NYSE:NJR), has completed a sale of company stock totaling $448,800. The transaction took place on May 8, 2026, involving the disposal of 8,000 shares of common stock at a price point of $56.10 per share. This movement comes as the company maintains a strong year-to-dat…

EU unveils proposed overhaul of state aid framework for regional airports

EU unveils proposed overhaul of state aid framework for regional airports

The European Commission has proposed changes to state aid rules for smaller airports, citing the bloc's decarbonisation targets and the energy crisis. The draft lowers the size threshold for investment aid tied to green conditions and removes the need for prior approval for operating aid at very small airports. Stakeholders have until June 11 to co…

Peak Greggs? My London Check Suggests the Growth Run Has More Legs

Peak Greggs? My London Check Suggests the Growth Run Has More Legs

Sentiment that Greggs has hit its ceiling is premature. A recent trip to London and conversations with managers, franchisees and store teams show demand still rising, new product tails gaining traction, and store economics improving. This trade idea outlines a long entry, layered targets across horizons, and the risks that could derail the thesis.

Palantir Reset: Tactical Long Setup After Sentiment Capitulation

Palantir Reset: Tactical Long Setup After Sentiment Capitulation

Palantir (PLTR) has re-priced lower after a stretch of execution skepticism. The shares now offer a high-conviction, defined-risk swing trade: buy into improving AI monetization and persistent government contracts with clear stops and two-tier targets. This plan balances upside from product-led revenue expansion against execution and concentration …

Acoramidis Continues to Demonstrate Disease-Modifying Effects in ATTR-CM, Reducing sTTR Variability and Outpatient Worsening Heart Failure

Acoramidis Continues to Demonstrate Disease-Modifying Effects in ATTR-CM, Reducing sTTR Variability and Outpatient Worsening Heart Failure

BridgeBio Pharma presented new Phase 3 data for its drug acoramidis demonstrating early and sustained reduction in serum transthyretin variability, outpatient worsening heart failure, and cardiovascular hospitalizations in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). The data show acoramidis improves survival and functional outcome…

Regulatory Approval Clears Path for Gas Production at Troll Phase 3 Stage 2

Regulatory Approval Clears Path for Gas Production at Troll Phase 3 Stage 2

Norway's petroleum safety regulator has authorized Equinor to commence gas production from the recently completed Troll Phase 3 stage 2 facilities. The development, built to accelerate gas output under the 2018 Troll phase 3 plan, includes eight new wells and a new flowline to the Troll A platform and represents a NOK 12 billion investment with an …

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy

Biodesix, Inc. announced presentations at the American Thoracic Society 2026 Annual Meeting showcasing real-world clinical data and healthcare system economic value of its Nodify Lung® blood-based testing for lung nodule risk stratification. The data highlights improvements in lung cancer detection and patient outcomes, supported by academic and co…

OpenAI Forms Deployment Unit With Brookfield Backing to Scale Enterprise AI

OpenAI Forms Deployment Unit With Brookfield Backing to Scale Enterprise AI

OpenAI has established the OpenAI Deployment Company, a majority-owned and controlled entity designed to help large enterprises take AI projects beyond pilot stages to organization-wide deployments. The platform consolidates 19 investment firms, consultancies and system integrators, will incorporate 150 engineers and deployment specialists from Tom…

The Boston Beer Company Lights Up Ready-To-Drink Market with All-New 15% Alc. LYTT® Electric Coolers™

The Boston Beer Company Lights Up Ready-To-Drink Market with All-New 15% Alc. LYTT® Electric Coolers™

The Boston Beer Company introduces LYTT® Electric Coolers, a new line of single-serve, 15% alcohol-by-volume ready-to-drink beverages packaged in patent-pending, glow-in-the-dark lightbulb-shaped containers. Launching in select U.S. markets in mid-2026, this product aims to capture a share of the growing high-alcohol ready-to-drink market with recy…

Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101

Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101

Ernexa Therapeutics released a Virtual Investor KOL Connect segment featuring insights from its Chief Scientific Officer on the complexities of ovarian cancer and the potential for their lead cell therapy candidate ERNA-101 to address existing treatment limitations. The company also announced participation in an upcoming Virtual Investor Closing Be…